Combo Therapy May Prevent Cancer’s Return After Liver Surgery
MONDAY, April 24, 2023 (HealthDay News) — A two-drug combination therapy can enhance survival odds for people with early-stage liver cancer through targeted attacks on tumor cells, a new clinical trial shows.The combo — atezolizumab (Tecentriq) and …
Learn MoreBlack Patients More Likely to Have Heart Damage Following Chemo
TUESDAY, April 18, 2023 (HealthDay News) — Black patients have 71 percent higher odds of cardiotoxicity following cancer treatment versus White patients, according to research presented at the Advancing the Cardiovascular Care of the Oncology Patient…
Learn MoreBlack Cancer Patients Much More Prone to Chemo-Linked Heart Trouble
FRIDAY, April 14, 2023 (HealthDay News) — Sometimes cancer, and the treatments meant to eradicate it, can damage the heart and blood vessels. Now, a new analysis finds that damage may be much more likely if the patient is Black. Black patients had 7…
Learn MoreGuideline Updated for Initial Management of Advanced Prostate Cancer
WEDNESDAY, April 12, 2023 (HealthDay News) — For patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen deprivation therapy (ADT),…
Learn MoreOutcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
MONDAY, Feb. 6, 2023 (HealthDay News) — Female patients with diffuse large B-cell lymphoma (DLBCL) have worse outcomes when receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in the morning, according to a st…
Learn MoreNeoadjuvant Oxaliplatin-Fluoropyrimidine Chemo Improves Colon Cancer Outcomes
WEDNESDAY, Feb. 1, 2023 (HealthDay News) — Six weeks of preoperative oxaliplatin-fluoropyrimidine chemotherapy is safe and effective for operable colon cancer, without increasing perioperative morbidity, according to a study published online Jan. 19 …
Learn MoreFemale Cancer Survivors Experience Accelerated Declines in Physical Function
TUESDAY, Jan. 24, 2023 (HealthDay News) — Female survivors of cancer experience accelerated declines in physical function after diagnosis versus matched controls, according to a study published online Jan. 19 in JAMA Oncology.Elizabeth M. Cespedes Fe…
Learn MoreSABCS: Updated Analysis Confirms Endocrine Therapy Effective With/Without Chemo
MONDAY, Dec. 12, 2022 (HealthDay News) — For patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-negative early breast cancer (EBC) with a 21-gene recurrence score (RS) of 11 to 25, adjuvant en…
Learn MoreUn implante administra quimioterapia directa a los cerebros de los pacientes con tumores cerebrales
MARTES, 22 de noviembre de 2022 (HealthDay News) — Unos investigadores encontraron una forma de administrar de forma segura un suministro de quimioterapia directamente en los tumores cerebrales, y esperan que esto sea un importante avance para los pa…
Learn MoreImplant Delivers Chemo Directly to Brain in Patients Battling Brain Tumors
TUESDAY, Nov. 22, 2022 (HealthDay News) — Researchers have found a way to safely deliver a steady supply of chemotherapy directly to brain tumors — in what they hope will be an important advance for patients with currently incurable cancers.The trea…
Learn More